glp 1 mecanismo de ação What is GLP-1 and Its Receptor Agonists? Implicações Laboratoriais do uso de

Theyre not FDA-regulated, theres no good evidence they work for weight loss, and honestly, theyre just going to waste your money and delay you from getting real help

Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users

RESOURCES View LifeScan Diabetes Institutes webinar, A Deep Dive Into GLP1 Agonists, and earn 1 CPEU through the Commission on Dietetic Registration

GLP-1s are so effective at helping people lose weight and improve their health that many patients fear going off of them

The whole way through, you stay in touch with the support team online

Liu, J., & Pang, Z